NKA Bio is developing new medicines to improve critical care. Our lead product is NKA01, a temperature-stable antibody for trauma patients. When you are severely injured, it is a race against time to get to surgery. The average person dies 8 minutes before lifesaving treatment can be delivered. But in the future, when minutes count, our antibody will buy hours. At NKA Bio, our treatment presses pause on death. With an injection of NKA01 by EMS, our drug could buy more time for transport and lifesaving surgery.
Company Details
- Employees
- 7
- Founded
- 2023
- Address
- 2401 W Belvedere Ave,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.nkabio.com
- Keywords
- Antibody Engineering, In Silico Drug Design, Trauma Care, Emergency Medicine, Trauma Surgery, Acute Care Surgery, Military Medicine, Combat Casualty Care, TCCC, Phage Display, Assay Development, Critical Care, ICU, Trauma Resuscitation, Hemorrhagic Shock, Hemorrhage Resuscitation, Septic Shock, Sepsis, Cardiogenic Shock, Heart Attack, Acute Lung Injury, ARDS, Bacterial Sepsis.
- HQ
- Baltimore, Maryland
Nka Bio (Techstars '24) Questions
Nka Bio (Techstars '24)'s website is http://www.nkabio.com
Nka Bio (Techstars '24)'s LinkedIn profile is https://www.linkedin.com/company/nkabio
Nka Bio (Techstars '24) has
7 employees.
View email and phone details for 7
employees at Nka Bio (Techstars '24).
Nka Bio (Techstars '24)'s industry is
Biotechnology Research
Nka Bio (Techstars '24)'s top competitors are
Equali,
Fasten Health (Techstars '24),
Syllotips Ii Techstars '24,
Nditive,
Reviewtailor,
Cluster (Techstars '24),
Inner Peak Ai (Techstars '24),
Gateway,
Inclusion Unpacked (Techstars '24),
Neurox1 Inc..
Nka Bio (Techstars '24)'s categories are Biotechnology Research
Nka Bio (Techstars '24)'s founding year is 2023
